Jones Trading analyst Boris Peaker assumes coverage on Monopar Therapeutics (NASDAQ: MNPR) with a Buy rating and a price target of $130.00.

For an analyst ratings summary and ratings history on Monopar Therapeutics click here. For more ratings news on Monopar Therapeutics click here.

Shares of Monopar Therapeutics closed at $55.13 yesterday.